Skip to content

Clinical Effectiveness of Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Grafts Donor Sites

The Clinical Effectiveness of Hydroxylated Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Graft Donor Sites

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05814003
Acronym
RCT
Enrollment
30
Registered
2023-04-14
Start date
2023-04-20
Completion date
2023-05-20
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession, Soft Tissue Infections

Brief summary

Free gingival grafting surgeries require palatal grafts harvesting from the patient own palates . The donor sites pain , infection and retarded healing by secondary intension are the complication .

Detailed description

After the preparation and characterization of the solid dispersion of hydroxylated methoxy flavones, free gingival grafting surgeries require palatal grafts harvesting from the patient own palates . The donor sites pain , infection and retarded healing by secondary intension are the complications ; the aim of the study is to assess the analgesic , anti inflammatory effects of hydroxylated methoxy flavones.

Interventions

DRUGhydroxylate flavones solid dispersion application

this drug has the antibacterial and anti inflammatory actions could help the palatal donor sites to promote the wound healing

OTHERPlacebo

Dough inert material without any therapeutic action

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* insufficient zone of keratinized gingiva recession of the gingiva non smokers free from systemic disorders

Exclusion criteria

* smokers insufficient palatal donor sits un realistic expectations

Design outcomes

Primary

MeasureTime frameDescription
post operative pain (VAS scale)first day postoperative to 30 days (days)VAS scale from 0 no pain to 10 excruciating pain (healing)

Secondary

MeasureTime frameDescription
Number of analgesic and anti inflammatory pills consumedfirst day postoperative to 30 days (days)Minimizing the pain and inflammation during healing process post operative swelling

Countries

Egypt

Contacts

Primary ContactAhmed Mortada, professor
mortadafikry@hotmail.com20 0100 543 2223

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026